ucsf logo

Kelly Schoenbeck, MD

Hematology • Medical Oncology
Hematology, Blood & Marrow Transplant, and Cellular Therapy (HBC) Parnassus
ucsf logo

Kelly Schoenbeck, MD

Hematology • Medical Oncology
Hematology, Blood & Marrow Transplant, and Cellular Therapy (HBC) Parnassus

On this page

Education & training

Board certification

  • Hematology, American Board of Internal Medicine/Hematology
  • Internal Medicine, American Board of Internal Medicine

Fellowship

  • Hematology - Oncology, UCSF Graduate Medical Education

Residency

  • Internal Medicine, New York Presbyterian Hospital/Columbia University

Internship

  • Internal Medicine, New York Presbyterian Hospital/Columbia University

Degree

  • MD, Oregon Health & Science University

My expertise

Locations

    Reviews

    Average rating

    4.9
    4.9 out of 5 Stars
    148 ratings
    About provider reviews

    Showing 1-6 of 33 reviews

    Sort by
    • 5 out of 5 Stars
      December 3, 2025

      Dr. Schoenbeck could not have been more patient and caring. She was simply terrific!

    • 5 out of 5 Stars
      November 28, 2025

      I really appreciate the time the provider took to understand my health history during the initial visit.

    • 5 out of 5 Stars
      September 19, 2025

      Again, a successful Appt.

    • 5 out of 5 Stars
      September 3, 2025

      Dr. Schoenbeck is excellent!

    • 5 out of 5 Stars
      August 13, 2025

      I could not find a better physician

    • 5 out of 5 Stars
      July 31, 2025

      Dr Schoenbeck is outstanding

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.